GBM Agile Archives - NFCR

GBM Agile

A Major Milestone! Global Coalition Launches World’s First Adaptive Clinical Trial Platform for Glioblastoma

Glioblastoma Multiforme (GBM) is the deadliest and most aggressive form of brain cancer for which there is currently no cure. This often-fatal brain cancer accounts for 45% of all malignant brain tumors and 12,000 cancer diagnoses per year in the United States, in addition to tens of thousands more around…...

Read more

Origin Cells of Glioblastoma May Have Been Identified

In what could be a major breakthrough, scientists at the Korea Advanced Institute of Science and Technology (KAIST) in South Korea claim to have identified the cellular origin of glioblastoma, a fast-growing type of central nervous system tumor that forms from supportive tissue of the brain and spinal cord. It…...

Read more

Global Coalition for Adaptive Research (GCAR) Names Gary Gordon Interim Chief Executive Officer

FOR IMMEDIATE RELEASE: November 8, 2018 CONTACT: Global Coalition for Adaptive Research Rachel Rosenstein-Sisson, Executive Assistant E-mail: rrosenstein.sisson@gcaresearch.org / Phone: 617-299-6471 National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Programs & Communications E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 LEXINGTON, MA & ROCKVILLE, MD – Gary Gordon, M.D., Ph.D.,…...

Read more